Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 4.55B 681M 618M 571M 515M 971M 64.25B 1.01B 6.86B 2.72B 34.32B 2.56B 2.5B 109B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.38B 656M 595M 550M 496M 935M 61.87B 968M 6.61B 2.62B 33.05B 2.46B 2.41B 105B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day-3.58%
1 week-1.51%
Current month-3.10%
1 month-5.56%
3 months-10.42%
6 months-12.53%
Current year-1.51%
1 week 7.77
Extreme 7.77000000
8.31
1 month 7.58
Extreme 7.58
8.41
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.38
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
14.86
Manager TitleAgeSince
Chief Executive Officer 42 2017-12-10
Director of Finance/CFO 34 2019-07-31
Chief Operating Officer 45 2022-08-24
Director TitleAgeSince
Chairman 42 2019-07-31
Chairman 48 2019-03-20
Director/Board Member 46 2019-03-20
Date Insider Type Main position Quantity % Market Cap. Importance
8/7/26 Sell

Executive/Senior Manager

-2,000 0.0005%
9/14/21 Sell

Executive/Senior Manager

10,000 0.0025%
9/10/21 Sell

Executive/Senior Manager

77,000 0.0189%
Change 5-day change 1-year change 3-year change Capi.($)
-3.58%-1.51%-14.07%+0.39% 681M
+1.26%+6.61%+40.79%+145.27% 1,286B
+0.79%+3.45%+45.84%+92.04% 688B
+0.20%+1.28%+26.97%+114.41% 521B
-0.44%+3.69%+41.45%+70.04% 386B
+0.55%+0.70%+59.02%+45.79% 364B
-0.12%+0.74%+28.39%+60.32% 302B
+0.37%+0.37%+3.33%+38.57% 287B
-0.30%+1.14%+38.29%+70.56% 252B
+0.08%+0.71%+34.44%+123.99% 208B
Average -0.12%+1.74%+30.45%+76.14% 429B
Weighted average by Cap. +0.54%+3.26%+37.69%+99.27%

Financials

2024 2025
Net sales 984M 147M 134M 124M 111M 210M 13.89B 217M 1.48B 588M 7.42B 553M 541M 23.56B 1.21B 181M 164M 151M 137M 257M 17.03B 266M 1.82B 721M 9.09B 678M 663M 28.87B
Net income 13.65M 2.05M 1.85M 1.71M 1.55M 2.91M 193M 3.02M 20.59M 8.17M 103M 7.67M 7.51M 327M 92.73M 13.89M 12.59M 11.64M 10.51M 19.8M 1.31B 20.5M 140M 55.47M 700M 52.13M 51.03M 2.22B
Net Debt 189M 28.33M 25.67M 23.74M 21.42M 40.37M 2.67B 41.79M 285M 113M 1.43B 106M 104M 4.53B -169M -25.29M -22.92M -21.2M -19.13M -36.04M -2.38B -37.31M -255M -101M -1.27B -94.9M -92.89M -4.04B
Projected Income Statement - Annual - Beijing Beilu Pharmaceutical Co., Ltd.
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
26-11-13 CN¥7.820 -3.58% 24,893,888
26-11-12 CN¥8.110 +0.12% 26,962,899
26-11-11 CN¥8.100 -0.25% 18,846,117
26-11-10 CN¥8.120 +2.53% 20,577,578
26-11-09 CN¥7.920 -0.25% 13,524,200

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Beijing Beilu Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 300016 Stock